Nuzenio

Cldx

Cldx news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 23 latest news signals 12 publisher sources 100/100 entity strength

Latest news

What Is Celldex Therapeutics (CLDX) Signaling With Its Mixed Pipeline Update? - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 21:15:24 GMT First Trust Advisors LP Has $2.17 Million Stock Holdings in Celldex Therapeutics, Inc. $CLDX - MarketBeatMarketBeat · Sat, 08 Aug 2026 08:41:01 GMT Celldex Therapeutics (NASDAQ:CLDX) Issues Earnings Results, Beats Estimates By $0.12 EPS - MarketBeatMarketBeat · Sat, 08 Aug 2026 04:52:38 GMT Morgan Stanley Boosts Celldex Therapeutics (NASDAQ:CLDX) Price Target to $46.00 - MarketBeatMarketBeat · Fri, 07 Aug 2026 19:21:23 GMT CLDX Oct 2026 41.000 call (CLDX261016C00041000) stock price, news, quote and history - Yahoo Finance AustraliaYahoo Finance Australia · Fri, 07 Aug 2026 16:34:35 GMT Barclays Forecasts Strong Price Appreciation for Celldex Therapeutics (NASDAQ:CLDX) Stock - MarketBeatMarketBeat · Fri, 07 Aug 2026 12:28:26 GMT CLDX SWOT Analysis: Financial Challenges and Opportunities Revea - GuruFocusGuruFocus · Fri, 07 Aug 2026 09:14:13 GMT Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 23:10:20 GMT

Timeline

Sat, 08 Aug 2026 21:15:24 GMTWhat Is Celldex Therapeutics (CLDX) Signaling With Its Mixed Pipeline Update? - Yahoo Finance

Sat, 08 Aug 2026 08:41:01 GMTFirst Trust Advisors LP Has $2.17 Million Stock Holdings in Celldex Therapeutics, Inc. $CLDX - MarketBeat

Sat, 08 Aug 2026 04:52:38 GMTCelldex Therapeutics (NASDAQ:CLDX) Issues Earnings Results, Beats Estimates By $0.12 EPS - MarketBeat

Fri, 07 Aug 2026 19:21:23 GMTMorgan Stanley Boosts Celldex Therapeutics (NASDAQ:CLDX) Price Target to $46.00 - MarketBeat

Fri, 07 Aug 2026 16:34:35 GMTCLDX Oct 2026 41.000 call (CLDX261016C00041000) stock price, news, quote and history - Yahoo Finance Australia

Fri, 07 Aug 2026 12:28:26 GMTBarclays Forecasts Strong Price Appreciation for Celldex Therapeutics (NASDAQ:CLDX) Stock - MarketBeat

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Celldex Therapeutics14 live mentions Inc12 live mentions NASDAQ12 live mentions Celldex Therapeutics Inc6 live mentions TradingKey Celldex Therapeutics6 live mentions Million Stock Holdings4 live mentions After Phase4 live mentions TradingKey4 live mentions Therapeutics3 live mentions Yahoo Finance Australia3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Cldx.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.